These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35226254)

  • 1. Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications.
    McMullan P; Germain-Lee EL
    Curr Osteoporos Rep; 2022 Feb; 20(1):78-89. PubMed ID: 35226254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotopic ossifications in a mouse model of albright hereditary osteodystrophy.
    Huso DL; Edie S; Levine MA; Schwindinger W; Wang Y; Jüppner H; Germain-Lee EL
    PLoS One; 2011; 6(6):e21755. PubMed ID: 21747923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy.
    Lin MH; Numbenjapon N; Germain-Lee EL; Pitukcheewanont P
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):911-8. PubMed ID: 25894639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification.
    Adegbite NS; Xu M; Kaplan FS; Shore EM; Pignolo RJ
    Am J Med Genet A; 2008 Jul; 146A(14):1788-96. PubMed ID: 18553568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNAS mutations and heterotopic ossification.
    Bastepe M
    Bone; 2018 Apr; 109():80-85. PubMed ID: 28889026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNAS gene mutations affecting XLαs and bone health: A long neglected relationship.
    Xie Y; Chen X; Xie Y; Yu X
    Clin Genet; 2023 Sep; 104(3):279-286. PubMed ID: 37249323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification.
    Pignolo RJ; Xu M; Russell E; Richardson A; Kaplan J; Billings PC; Kaplan FS; Shore EM
    J Bone Miner Res; 2011 Nov; 26(11):2647-55. PubMed ID: 21812029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
    Kottler ML
    Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental Origin of
    McMullan P; Maye P; Yang Q; Rowe DW; Germain-Lee EL
    JBMR Plus; 2022 Jan; 6(1):e10570. PubMed ID: 35079678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the variety of GNAS inactivation disorders and their clinical manifestations in 11 Chinese children.
    Chang G; Li Q; Li N; Li G; Li J; Ding Y; Huang X; Shen Y; Wang J; Wang X
    BMC Endocr Disord; 2022 Mar; 22(1):70. PubMed ID: 35296306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ossifications in Albright Hereditary Osteodystrophy: Role of Genotype, Inheritance, Sex, Age, Hormonal Status, and BMI.
    Salemi P; Skalamera Olson JM; Dickson LE; Germain-Lee EL
    J Clin Endocrinol Metab; 2018 Jan; 103(1):158-168. PubMed ID: 29059381
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yang W; Zuo Y; Zhang N; Wang K; Zhang R; Chen Z; He Q
    Front Endocrinol (Lausanne); 2023; 14():1255864. PubMed ID: 37920253
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B/iPPSD3.
    Elli FM; deSanctis L; Maffini MA; Bordogna P; Tessaris D; Pirelli A; Arosio M; Linglart A; Mantovani G
    Clin Epigenetics; 2019 Jan; 11(1):3. PubMed ID: 30616679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
    Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone development.
    Krishnan N; McMullan P; Yang Q; Buscarello AN; Germain-Lee EL
    PLoS One; 2023; 18(1):e0280463. PubMed ID: 36662765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification.
    Regard JB; Malhotra D; Gvozdenovic-Jeremic J; Josey M; Chen M; Weinstein LS; Lu J; Shore EM; Kaplan FS; Yang Y
    Nat Med; 2013 Nov; 19(11):1505-12. PubMed ID: 24076664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.
    Lemos MC; Thakker RV
    Hum Mutat; 2015 Jan; 36(1):11-9. PubMed ID: 25219572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up Findings in a Turkish Girl with Pseudohypoparathyroidism Type Ia Caused by a Novel Heterozygous Mutation in the GNAS Gene.
    Şahin S; Hiort O; Thiele S; Evliyaoğlu O; Tüysüz B
    J Clin Res Pediatr Endocrinol; 2017 Mar; 9(1):74-79. PubMed ID: 27425121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective deficiency of Gsalpha and the possible role of alternative gene products of GNAS in Albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia.
    Thiele S; Werner R; Ahrens W; Hübner A; Hinkel KG; Höppner W; Igl B; Hiort O
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):127-32. PubMed ID: 19658058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medulloblastoma in a child with osteoma cutis - a rare association due to loss of
    Suntharesan J; Lyulcheva-Bennett E; Hart R; Pizer B; Hayden J; Ramakrishnan R
    J Pediatr Endocrinol Metab; 2024 May; 37(5):467-471. PubMed ID: 38529810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.